These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 17470597)

  • 21. Factor XII deficiency is strongly associated with primary recurrent abortions.
    Pauer HU; Burfeind P; Köstering H; Emons G; Hinney B
    Fertil Steril; 2003 Sep; 80(3):590-4. PubMed ID: 12969703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polymorphisms in MTHFR, MTHFD, and PAI-1 and recurrent miscarriage among North Indian women.
    Parveen F; Tuteja M; Agrawal S
    Arch Gynecol Obstet; 2013 Nov; 288(5):1171-7. PubMed ID: 23685927
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma fibrinolytic activators and their inhibitors in women suffering from early recurrent abortion of unknown etiology.
    Gris JC; Neveu S; Mares P; Biron C; Hedon B; Schved JF
    J Lab Clin Med; 1993 Nov; 122(5):606-15. PubMed ID: 8228580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genotyping analysis for the 46 C/T polymorphism of coagulation factor XII and the involvement of factor XII activity in patients with recurrent pregnancy loss.
    Asano E; Ebara T; Yamada-Namikawa C; Kitaori T; Suzumori N; Katano K; Ozaki Y; Nakanishi M; Sugiura-Ogasawara M
    PLoS One; 2014; 9(12):e114452. PubMed ID: 25489738
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polymorphisms in the fibrinolytic pathway genes and the risk of recurrent spontaneous abortion.
    Andraweera PH; Dekker GA; Thompson SD; Nowak RC; Jayasekara RW; Dissanayake VH; Roberts CT
    Reprod Biomed Online; 2014 Dec; 29(6):745-51. PubMed ID: 25444509
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of thrombophilic gene mutations among patients experiencing recurrent miscarriage and deep vein thrombosis.
    Coulam CB; Wallis D; Weinstein J; DasGupta DS; Jeyendran RS
    Am J Reprod Immunol; 2008 Nov; 60(5):426-31. PubMed ID: 18803625
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduction of contact activation related fibrinolytic activity in factor XII deficient patients. Further evidence for the role of the contact system in fibrinolysis in vivo.
    Levi M; Hack CE; de Boer JP; Brandjes DP; Büller HR; ten Cate JW
    J Clin Invest; 1991 Oct; 88(4):1155-60. PubMed ID: 1833421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fibrinolytic studies in 13 unrelated families with factor XII deficiency.
    Rodeghiero F; Castaman G; Ruggeri M; Cazzavillan M; Ferracin G; Dini E
    Haematologica; 1991; 76(1):28-32. PubMed ID: 2055558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of the F13A1 Val34Leu polymorphism and recurrent pregnancy loss: A meta-analysis.
    Jung JH; Kim JH; Song GG; Choi SJ
    Eur J Obstet Gynecol Reprod Biol; 2017 Aug; 215():234-240. PubMed ID: 28683377
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synergism between factor XII -4C>T and factor XIII Val34Leu polymorphisms in fibrinolytic therapy in acute myocardial infarction.
    Hernández-Romero D; Marín F; Lee KW; Roldán V; Caturla J; Corral J; Valdés M; Lip GY; Vicente V; González-Conejero R
    Thromb Haemost; 2010 Sep; 104(3):650-2. PubMed ID: 20589311
    [No Abstract]   [Full Text] [Related]  

  • 31. Prevalence of the coagulation factor XIII polymorphism Val34Leu in women with recurrent miscarriage.
    López Ramírez Y; Vivenes M; Miller A; Pulido A; López Mora J; Arocha-Piñango CL; Marchi R
    Clin Chim Acta; 2006 Dec; 374(1-2):69-74. PubMed ID: 16844105
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polymorphisms in NOS3, ACE and PAI-1 genes and risk of spontaneous recurrent miscarriage in the Gaza Strip.
    Al Sallout RJ; Sharif FA
    Med Princ Pract; 2010; 19(2):99-104. PubMed ID: 20134171
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation between factor VII and PAI-1 genetic variants and recurrent miscarriage.
    Barlik M; Seremak-Mrozikiewicz A; Drews K; Klejewski A; Kurzawińska G; Łowicki Z; Wolski H
    Ginekol Pol; 2016; 87(7):504-9. PubMed ID: 27504943
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Plasminogen activator inhibitor type 1 activity in women with unexplained very early recurrent pregnancy loss].
    Ivanov P; Komsa-Penkova R; Ivanov I; Konova E; Kovacheva K; Simeonova M; Tanchev S
    Akush Ginekol (Sofiia); 2010; 49(5):3-8. PubMed ID: 21268395
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation between plasminogen activator inhibitor-1 4G/5G polymorphism and pre-eclampsia: an appraisal.
    Wiwanitkit V
    Arch Gynecol Obstet; 2006 Mar; 273(6):322-4. PubMed ID: 16502012
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Family history and risk of miscarriage: A systematic review and meta-analysis of observational studies.
    Woolner AMF; Nagdeve P; Raja EA; Bhattacharya S; Bhattacharya S
    Acta Obstet Gynecol Scand; 2020 Dec; 99(12):1584-1594. PubMed ID: 32557529
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The association of factor V G1961A (factor V Leiden), prothrombin G20210A, MTHFR C677T and PAI-1 4G/5G polymorphisms with recurrent pregnancy loss in Bosnian women.
    Jusić A; Balić D; Avdić A; Pođanin M; Balić A
    Med Glas (Zenica); 2018 Aug; 15(2):158-163. PubMed ID: 29703881
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between the plasminogen activator inhibitor-1 4G/5G polymorphism and venous thrombosis. A meta-analysis.
    Tsantes AE; Nikolopoulos GK; Bagos PG; Rapti E; Mantzios G; Kapsimali V; Travlou A
    Thromb Haemost; 2007 Jun; 97(6):907-13. PubMed ID: 17549286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ABO blood group but not haemostasis genetic polymorphisms significantly influence thrombotic risk: a study of 180 homozygotes for the Factor V Leiden mutation.
    Procare-GEHT Group
    Br J Haematol; 2006 Dec; 135(5):697-702. PubMed ID: 17107352
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Components of the fibrinolytic system are differently altered in moderate and severe hypothyroidism.
    Chadarevian R; Bruckert E; Leenhardt L; Giral P; Ankri A; Turpin G
    J Clin Endocrinol Metab; 2001 Feb; 86(2):732-7. PubMed ID: 11158038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.